敲除NOR1基因对人肝癌裸鼠移植瘤的影响及作用机制

游焜; 王大军; 王亮; 王建国

doi:10.3969/j.issn.1001-5256.2020.02.030

敲除NOR1基因对人肝癌裸鼠移植瘤的影响及作用机制

DOI: 10.3969/j.issn.1001-5256.2020.02.030

新乡医学院第一附属医院肝胆外科

基金项目:

河南省教育厅(20007320017)；

详细信息

中图分类号: R735.7
计量
- 文章访问数: 1098
- HTML全文浏览量: 38
- PDF下载量: 202
- 被引次数: 0
出版历程
- 收稿日期: 2019-08-14
- 出版日期: 2020-02-20

Effect of NOR1 gene knockout on nude mice xenograft tumor of human liver cancer and its mechanism of action

Department of Hepatobiliary Surgery,The First Affiliated Hospital of Xinxiang Medical College

Research funding:

摘要

摘要:
目的探究敲除NOR1基因后对人肝癌裸鼠移植瘤生长、存活率及器官损伤的影响。方法 SPF级雄性BALB/C裸鼠30只随机分为Control组（n=10）、Scramble组（n=10）、siNOR1组（n=10）,构建阴性对照质粒（Scramble）和siNOR1质粒转染至HepG2细胞并接种至裸鼠构建移植瘤裸鼠模型。连续30 d每5 d检测裸鼠移植瘤组织体积;检测移植瘤重量;免疫组化检测Ki-67、Caspase-3、Notch、NOR1表达情况; Western Blot检测Survivin、Notch1、NICD、Hes1、Hey1蛋白表达量情况,HE染色观察肝、肾、肺、脑病理损伤程度。计量资料多组间比较采用单因素方差分析,进一步两两比较采用LSD-t检验;生存分析采用Kaplan-Meier法,生存率的比较采用log-rank检验法。结果从建模第20天开始,与Control组相比,siNOR1组第20、25、30天移植瘤体积显著减小[（418. 71±78. 24） mm3vs （149. 6. 16±60. 05） mm3、（864. 22±125. 66） mm3vs （23...
- 肝肿瘤 /
- 小鼠,近交BALB C /
- NOR1基因
Abstract:
Objective To investigate the effect of NOR1 gene knockout on the growth of nude mice xenograft tumor of human liver cancer,the survival rate of nude mice,and organ damage in nude mice. Methods A total of 30 specific pathogen-free male BALB/C nude mice were randomly divided into control group,Scramble group,and siNOR1 group,with 10 mice in each group. The negative control plasmid( Scramble) and siNOR1 plasmid were transfected into HepG2 cells,and then the HepG2 cells were inoculated into nude mice to establish a nude mouse model of xenograft tumor. The volume and weight of nude mice xenograft tumor were measured every 5 days for 30 consecutive days. Immunohistochemistry was used to measure the expression of Ki-67,caspase-3,Notch,and NOR1,and Western Blot was used to measure the protein expression of Survivin,Notch1,NICD,Hes1,and Hey1. HE staining was used to observe the degree of pathological injury in the liver,the kidney,the lungs,and the brain. A one-way analysis of variance was used for comparison between multiple groups,and the least significant difference t-test was used for further comparison between two groups. The Kaplan-Meier method was used for survival analysis,and the log-rank test was used for comparison of survival rates. Results Compared with the control group since day 20 of modeling,the siNOR1 group had a significantly lower volume of xenograft tumor on days 20,25,and 30( day 20: 149. 6. 16 ± 60. 05 mm3 vs 418. 71 ± 78. 24 mm3,P < 0. 05; day 25: 239. 83 ± 100. 51 mm3 vs 864. 22 ± 125. 66 mm3,P < 0. 05; day 30: 446. 54 ± 147. 09 mm3 vs1468. 45 ± 199. 78 mm3,all P < 0. 05). The xenograft tumor was collected on day 30,and compared with the control group,the siNOR1 group had a significantly lower weight of xenograft tumor( 0. 12 ± 0. 04 g vs 0. 45 ± 0. 07 g,P < 0. 05). Compared with the control group,the siNOR1 group had significantly lower expression of Ki-67,Notch,and NOR1 in xenograft tumor tissue( Ki-67: 11. 51% ± 5. 09% vs48. 98% ± 9. 75%,P < 0. 05; Notch: 18. 75% ± 4. 61% vs 62. 51% ± 9. 26%,P < 0. 05; NOR1: 16. 57% ± 3. 76% vs 76. 33% ±8. 31%,P < 0. 05),as well as significantly higher expression of caspase-3( 38. 03% ± 9. 28% vs 6. 39% ± 4. 67%,P < 0. 05). The siNOR1 group had a significantly higher 30-day survival rate than the control group( 77. 66% ± 6. 75% vs 25. 32% ± 4. 63%,χ2= 6. 897,P < 0. 05). Western blot showed that compared with the control group,the si NOR1 group had significantly lower protein expression of Survivin( 0. 02 ± 0. 01 vs 0. 34 ± 0. 06,P < 0. 05),Notch1( 0. 03 ± 0. 01 vs 0. 16 ± 0. 03,P < 0. 05),NICD( 0. 04 ± 0. 02 vs 0. 26 ± 0. 05,P < 0. 05),Hes1( 0. 06 ± 0. 02 vs 0. 35 ± 0. 04,P < 0. 05),and Hey1( 0. 05 ± 0. 02 vs 0. 29 ± 0. 06,P < 0. 05). The si NOR1 group had a significant improvement in organ damage. Conclusion NOR1 gene knockout inhibits the growth of nude mice xenograft tumor of human liver cancer,improve the survival rate of model nude mice,and alleviate the damage of the liver,the kidney,the lungs,and the brain in model nude mice,possibly by inhibiting the activity of the Notch signaling pathway.
- liver neoplasms /
- mice,inbred BALB C /
- NOR1 gene

HTML全文

参考文献(24)

[1] NIAN SY,FENG L. miR-548c-3p inhibits cell proliferation,migration and invasion of hepatocellular carcinoma HepG2cells by targeting TRIM59[J]. J Mol Diagn Ther,2019,11(4):283-289.(in Chinese)年士艳，冯磊．miR-548c-3p通过调控TRIM59表达对肝癌细胞增殖、侵袭和迁移的影响[J]．分子诊断与治疗杂志，2019,11(4):283-289.

[2] LLOVET JM,VILLANUEVA A. Liver cancer:Effect of HCV clearance with direct-acting antiviral agents on HCC[J]. Nat Rev Gastroenterol Hepatol,2016,13(10):561-562.

[3] XIE Y. Hepatitis B virus-associated hepatocellular carcinoma[J]. Adv Exp Med Biol,2017,1018:11-21.

[4] KEW MC. Aflatoxins as a cause of hepatocellular carcinoma[J]. J Gastrointestin Liver Dis,2013,22(3):305-310.

[5] GREWAL P,VISWANATHEN VA. Liver cancer and alcohol[J].Clin Liver Dis,2012,16(4):839-850.

[6] MARENGO A,ROSSO C,BUGIANESI E. Liver cancer:Connections with obesity,fatty liver,and cirrhosis[J]. Annu Rev Med,2016,67:103-117.

[7] NIE X,ZHANG B,LI X,et al. Cloning,expression,and mutation analysis of NOR1,a novel human gene down-regulated in HNE1 nasopharyngeal carcinoma cell line[J]. J Cancer Res Clin Oncol,2003,129(7):410-414.

[8] CHEN S,ZHENG P,WANG W,et al. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma[J]. J Cell Physiol,2018,233(6):5002-5013.

[9] SURESH S,IRVINE AE. The NOTCH signaling pathway in normal and malignant blood cell production[J]. J Cell Commun Signal,2015,9(1):5-13.

[10] HU GJ,LIU JZ,SHI LL,et al. Effects of blocking Notch signaling pathway on cell migration and expression of COX-2protein in hepatocellular carcinoma cells[J]. J Clin Exp Med,2018,17(2):132-134.(in Chinese)胡广军，刘建中，时玲玲，等．阻断Notch信号通路对肝癌细胞迁移和COX-2蛋白表达的影响[J]．临床和实验医学杂志，2018,17(2):132-134.

[11] DUAN YF,ZHAO QX,JING X. Effect of long non-coding RNAs on glycolytic pathway in primary liver cancer and related mechanisms[J]. J Clin Hepatol,2019,35(6):1374-1376.(in Chinese)段艺菲，赵清喜，荆雪．长链非编码RNA对原发性肝癌中糖酵解途径的影响机制[J]．临床肝胆病杂志，2019,35(6):1374-1376.

[12] CHANG QQ,PENG Y,WANG GJ,et al. Clinical research progress of small molecule tyrosine kinase inhibitors as antihepatocellular carcinoma agents[J]. Chin J Clin Pharmacol Ther,2019,24(8):948-956.(in Chinese)常青青，彭英，王广基，等．抗肝癌小分子酪氨酸激酶抑制剂的临床研究进展[J]．中国临床药理学与治疗学，2019,24(8):948-956.

[13] WU G,WILSON G,GEORGE J,et al. Modulation of Notch signaling as a therapeutic approach for liver cancer[J]. Curr Gene Ther,2015,15(2):171-181.

[14] ZHAO SY,LEI YJ,MA SJ,et al. Solanum nigrum combined with KLF16 gene synergistically inhibit glioma cell proliferation and induce apoptosis[J]. J Mol Diagn Ther,2019,11(4):303-309.(in Chinese)赵舒杨，雷艳杰，马世杰，等．龙葵碱联合KLF16基因对胶质瘤细胞增殖、凋亡的影响及其机制研究[J]．分子诊断与治疗杂志，2019,11(4):303-309.

[15] MATHIASEN IS,JAATTELA M. Triggering caspase-independent cell death to combat cancer[J]. Trends Mol Med,2002,8(5):212-220.

[16] OLSSON M,ZHIVOTOVSKY B. Caspases and cancer[J]. Cel Death Differ,2011,18(9):1441-1449.

[17] XIANG B,YI M,LI W,et al. Expression of oxidored nitro domain-containing protein 1(NOR1)impairs nasopharyngeal carcinoma cells adaptation to hypoxia and inhibits PDK1 expression[J]. Mol Cel Biochem,2014,393(1-2):293-300.

[18] XIANG B,WANG W,LI W,et al. Differential expression of oxidored nitro domain containing protein 1(NOR1),in mouse tissues and in normal and cancerous human tissues[J]. Gene,2012,493(1):18-26.

[19] GUO XD,LI ZW,YANG M,et al. Expression of Caspase-9and Survivin in hepatocellular carcinoma tissues and its clinical significance[J]. J Clin Hepatol,2014,30(3):253-256.(in Chinese)郭晓东，李志伟，杨美，等．Caspase-9和Survivin在肝癌组织中的表达及意义[J]．临床肝胆病杂志，2014,30(3):253-256.

[20] WANG H,ZANG C,LIU XS,et al. The role of Notch receptors in transcriptional regulation[J]. J Cell Physiol,2015,230(5):982-988.

[21] LI J,MA R,CAO Z,et al. Correlations of MRI manifestations with survivin gene expression in primary hepatic carcinoma[J]. Cancer Biomark,2018,23(1):45-51.

[22] YOU K,SUN P,YUE Z,et al. NOR1 promotes hepatocellular carcinoma cell proliferation and migration through modulating the Notch signaling pathway[J]. Exp Cell Res,2017,352(2):375-381.

[23] LIU J,LIN PC,ZHOU BP. Inflammation fuels tumor progress and metastasis[J]. Curr Pharm Des,2015,21(21):3032-3040.

[24] ZHU JN,JIANG L,JIANG JH,et al. Hepatocyte nuclear factor-1beta enhances the stemness of hepatocellular carcinoma cells through activation of the Notch pathway[J]. Sci Rep,2017,7(1):4793.

施引文献

资源附件(0)

访问统计